Looking beyond the spin of Big Pharma PR. But encouraging gossip. Come in and confide, you know you want to! “I’ll publish right or wrong. Fools are my theme, let satire be my song.”
Email: jackfriday2011(at)hotmail.co.uk
Monday, April 18, 2011
FT.com / Companies / Healthcare - Deal could be cure for Johnson & Johnson
A successful bid for Synthes, the Swiss medical device maker, could be timely medicine for Johnson & Johnson after a year plagued by product recalls and bribery allegations.
No comments:
Post a Comment